PP
HELP

PDS Planning’s Helus Pharma Inc. Common Stock HELP Stock Holding History

PDS Planning’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Hold
30,344
– – 0.01% 578
2026
Q1 		$145K Hold
30,344
– – 0.01% 538
2025
Q4 		$248K Hold
30,344
– – 0.02% 438
2025
Q3 		$179K Hold
30,344
– – 0.01% 513
2025
Q2 		$255K Hold
30,344
– – 0.02% 402
2025
Q1 		$192K Hold
30,344
– – 0.02% 443
2024
Q4 		$268K Sell
30,344
-237,236
-89% -$2.41M 0.02% 324
2024
Q3 		$2.38M Buy
267,580
+237,235
+782% +$2.35M 0.21% 60
2024
Q2 		$312K Hold
30,345
– – 0.03% 248
2024
Q1 		$477K Hold
30,345
– – 0.05% 172
2023
Q4 		$473K Buy
+30,345
New +$565K 0.05% 156

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

PDS Planning's HELP Position: Q2 2026 in Review

PDS Planning held its Helus Pharma Inc. Common Stock (HELP) position steady in Q2 2026 at 30,344 shares worth $201K. The position accounts for 0.01% of the portfolio, ranked #578.

PDS Planning first reported a position in HELP in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.38M in Q3 2024. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • PDS Planning held 30,344 shares of Helus Pharma Inc. Common Stock worth $201K as of Q2 2026.
  • PDS Planning left its Helus Pharma Inc. Common Stock share count unchanged in Q2 2026.
  • Helus Pharma Inc. Common Stock made up 0.01% of PDS Planning's portfolio in Q2 2026, its #578 holding.
  • PDS Planning first reported a position in Helus Pharma Inc. Common Stock in Q4 2023 and has held it in 11 quarters since.
  • PDS Planning's Helus Pharma Inc. Common Stock position peaked at $2.38M in Q3 2024.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on PDS Planning's 13F filing for Q2 2026, filed 5 Aug 2026.